Epidemiology of Eye Cancer in Cali, Colombia: A 55-Year Study.

IF 1.7 4区医学 Q3 OPHTHALMOLOGY

Ophthalmic epidemiology Pub Date : 2024-08-01 Epub Date: 2023-10-17 DOI:10.1080/09286586.2023.2269253

Katherine Vega-Escobar, Francisco J Bonilla-Escobar, Omar Salamanca, Alexander M Martinez-Blanco, Luz Stella Garcia, Paola Collazos, Luis Eduardo Bravo

{"title":"Epidemiology of Eye Cancer in Cali, Colombia: A 55-Year Study.","authors":"Katherine Vega-Escobar, Francisco J Bonilla-Escobar, Omar Salamanca, Alexander M Martinez-Blanco, Luz Stella Garcia, Paola Collazos, Luis Eduardo Bravo","doi":"10.1080/09286586.2023.2269253","DOIUrl":null,"url":null,"abstract":"Purpose: To describe the epidemiology, incidence, mortality and survival of ocular cancer in Cali between 1962 and 2019.Methods: Ecological population-based study analyzing data of incidence, mortality, and 5-years survival of malignant ocular tumors from the Populational Cancer Registry of Cali between 1962 and 2019.Results: Between 1962 and 2019, 586 ocular tumors were found, 50.5% occurred in females, the mean age at diagnosis was 45 years (standard deviation = 25), 70.3% of ocular malignancies occurred in >14 years. The average annual incidence rate was 7.8 per million for male and 6.9 per million for females. Retinoblastoma (21%), squamous cell carcinoma (20%), melanoma (16%) and lymphoma (8%) were the most common neoplasm. In those <15 years, the most frequent malignant tumors were retinoblastomas (85.7%), followed by non-specified malignant neoplasm (NOS, 7.9%), and rhabdomyosarcoma (3.6%). In those >14 years, there were NOS (30%), followed by squamous cell carcinomas (28%), melanomas (23%), and lymphomas (9.7%). Conjunctiva (38.2%), retina (21%) and orbit (10%) constituted the majority of anatomical sites of ocular tumors. The survival rate was about 83.2% and mortality did not show a decreasing trend over time (p > .05).Conclusions: The incidence of ocular cancer in Cali has a slightly increasing trend, with stable behavior in the last decades. Squamous cell carcinoma, retinoblastoma, melanoma and lymphoma are the most frequent ocular cancers, with being retinoblastoma more frequent than melanoma. In general, ocular cancer had good survival rates in Cali.","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"374-384"},"PeriodicalIF":1.7000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2023.2269253","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To describe the epidemiology, incidence, mortality and survival of ocular cancer in Cali between 1962 and 2019.

Methods: Ecological population-based study analyzing data of incidence, mortality, and 5-years survival of malignant ocular tumors from the Populational Cancer Registry of Cali between 1962 and 2019.

Results: Between 1962 and 2019, 586 ocular tumors were found, 50.5% occurred in females, the mean age at diagnosis was 45 years (standard deviation = 25), 70.3% of ocular malignancies occurred in >14 years. The average annual incidence rate was 7.8 per million for male and 6.9 per million for females. Retinoblastoma (21%), squamous cell carcinoma (20%), melanoma (16%) and lymphoma (8%) were the most common neoplasm. In those <15 years, the most frequent malignant tumors were retinoblastomas (85.7%), followed by non-specified malignant neoplasm (NOS, 7.9%), and rhabdomyosarcoma (3.6%). In those >14 years, there were NOS (30%), followed by squamous cell carcinomas (28%), melanomas (23%), and lymphomas (9.7%). Conjunctiva (38.2%), retina (21%) and orbit (10%) constituted the majority of anatomical sites of ocular tumors. The survival rate was about 83.2% and mortality did not show a decreasing trend over time (p > .05).

Conclusions: The incidence of ocular cancer in Cali has a slightly increasing trend, with stable behavior in the last decades. Squamous cell carcinoma, retinoblastoma, melanoma and lymphoma are the most frequent ocular cancers, with being retinoblastoma more frequent than melanoma. In general, ocular cancer had good survival rates in Cali.

查看原文本刊更多论文

哥伦比亚卡利眼癌症流行病学：55年研究。

目的：描述1962年至2019年间卡利眼癌症的流行病学、发病率、死亡率和生存率。方法：基于生态人群的研究，分析1962年至19年间卡利癌症人群登记处恶性眼肿瘤的发病率、死亡率和5年生存率数据，50.5%发生在女性中，诊断时的平均年龄为45岁年（标准偏差 = 25），70.3%的眼部恶性肿瘤发生在 >14 年。男性的年平均发病率为7.8/百万，女性为6.9/百万。视网膜母细胞瘤（21%）、鳞状细胞癌（20%）、黑色素瘤（16%）和淋巴瘤（8%）是最常见的肿瘤。在那些 14 年，NOS（30%），其次是鳞状细胞癌（28%）、黑色素瘤（23%）和淋巴瘤（9.7%）。结膜（38.2%）、视网膜（21%）和眼眶（10%）是眼部肿瘤的主要解剖部位。生存率约为83.2%，死亡率没有随时间的推移呈下降趋势（p > .结论：卡利市癌症的发病率有小幅上升的趋势，近几十年来表现稳定。鳞状细胞癌、视网膜母细胞瘤、黑色素瘤和淋巴瘤是最常见的眼癌，其中视网膜母细胞癌比黑色素瘤更常见。总体而言，卡利的眼癌症具有良好的生存率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmic epidemiology 医学-眼科学

CiteScore

3.70

自引率

5.60%

发文量

审稿时长

6-12 weeks

期刊介绍： Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.